JunHe Assists Innm88 live casinoorce Pharmaceuticals in Completing its Series A Financing

In March 2021, Zhejiang Innm88 live casinoorce Pharmaceutical Co., Ltd. (Innm88 live casinoorce), a biopharmaceutical company backed up by innovation and partnership cooperation, announced the completion m88 live casino its RMB 625 million Series A financing. This is another milestone for the Company after its RMB170 million Pre-A financing in June 2020.

This round m88 live casino financing was jointly led by South China Venture Capital (SCVC) and Yanchuang Capital and was actively followed by Quan Capital Management and several other well-known enterprises. JunHe acted once again as Innm88 live casinoorce’s legal counsel, after its Pre-A financing last year, and provided legal services to effectively complete this round m88 live casino financing.

Innm88 live casinoorce is a key enterprise in the Hangzhou Bay Biotech Valley and has established global product development and biopharmaceutical manufacturing capabilities to facilitate the development and commercialization m88 live casino innovative medicines. The raised funds will accelerate the construction m88 live casino Innm88 live casinoorce's campus in Hangzhou, China, and provide global GMP biopharmaceutical production capacity. This includes the establishment m88 live casino cell and gene therapy production and monoclonal antibody production facilities in partnership with Thermo Fisher Scientific. The company's business model will accelerate the development m88 live casino innovative medicines and their commercialization in China, the U.S. and Europe.

Innm88 live casinoorce will continue to establish biopharmaceutical ecosystems, providing tailor-made drug development, operations management and other services to their partners, as well as extensive support for start-up companies.

The complexity m88 live casino the project lies in: (1) the large number m88 live casino investors – there were seven investors and 13 investment entities; and (2) the involvement m88 live casino RMB capital and US dollar capital, and the entire transaction was divided into different rounds m88 live casino delivery. The project’s working group assisted the company in negotiating with the two leading investors while considering the opinions m88 live casino many investors. The project’s schedule was very tight and there were differences between the interests and concerns m88 live casino the investors. JunHe assisted the company in analyzing the interests m88 live casino the investors, determining the optimal negotiation strategy, and designing the financing transaction structure. On the day m88 live casino signing the transaction documents, the first round m88 live casino financing transaction was completed, which was fully recognized and praised by the clients. Prior to this round m88 live casino financing, JunHe had assisted Innm88 live casinoorce to complete their Pre-A round m88 live casino financing.

Under the agreements, the partners will form a Sino-foreign joint venture, which will operate with a total expected cost m88 live casino approximately one billion RMB. The complex venture will produce products that serve the growing demands m88 live casino various industries in China, including packaging, transportation, building and construction, healthcare and hygiene.

The leading partners m88 live casino this project were Mr., Mr.M88 Malaysia 于君合上海分所执业。.